Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

1998 ◽  
Vol 5 (5) ◽  
pp. 469-477 ◽  
Author(s):  
Carl Dahlof ◽  
Leon Hogenhuis ◽  
Jes Olesen ◽  
Henri Petit ◽  
Jacques Ribbat ◽  
...  
Cephalalgia ◽  
1989 ◽  
Vol 9 (9_suppl) ◽  
pp. 73-77
Author(s):  
P Tfelt-Hansen ◽  
J Brand ◽  
P Dano ◽  
A Doenicke ◽  
LJ Findley ◽  
...  

In six European clinics 111 migraine patients were treated in a series of open dose-ranging studies with subcutaneous injections of 1 to 4 mg GR43175, a novel 5-HT1-like receptor agonist. Response rates after 20–30 min were dose related and rose from 33% with 1 mg to 96% with 4 mg GR43175. Side effects were minor and transient. These promising results warrant confirmation in placebo-controlled double-blind trials.


2005 ◽  
Vol 173 (4S) ◽  
pp. 379-380
Author(s):  
James E. Kennedy ◽  
Rowland O. Illing ◽  
Feng Wu ◽  
Gail R. ter Haar ◽  
Rachel R. Phillips ◽  
...  

2004 ◽  
Vol 7 (5) ◽  
pp. E498-E502 ◽  
Author(s):  
Friedrich S. Eckstein ◽  
Hendrik Tevaearai ◽  
Dorothee Keller ◽  
Jürg Schmidli ◽  
Franz F. ◽  
...  

2001 ◽  
Vol 8 (4) ◽  
pp. 329-338 ◽  
Author(s):  
Khalid Irshad ◽  
Donald B. Reid ◽  
Peter H. Miller ◽  
Raj Velu ◽  
George E. Kopchok ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document